Renalys Pharma reports major phase III success for Sparsentan in Japanese IgA nephropathy patients
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
The fresh capital will propel Cordance into its first-in-human clinical trial
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Subscribe To Our Newsletter & Stay Updated